Clin2
NCT07164937Possibly a fitEnrolling by invitation

Imaging and gait study for FSHD patients

FSHD - Facioscapulohumeral Muscular Dystrophy

Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital clinical trials.

This study looks at muscle MRI images and walking patterns (3D gait analysis) in people with FSHD. It helps researchers understand how the disease affects movement and muscle over time.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older.
  • You have been diagnosed with FSHD (confirmed by genetic testing).
  • You have already had a muscle MRI done.
  • You have already had a 3D gait analysis done.
  • The MRI and gait analysis were done within 6 months of each other.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06911190Recruiting
10-year follow-up study for FSHD patients

This study follows FSHD patients for 10 years to see how the disease progresses. It includes people who were in earlier FSHD studies and some new patients with genetic confirmation of FSHD.

Nijmegen
NCT07086521Recruiting· Phase 1
Stem cell therapy for facioscapulohumeral muscular dystrophy

This trial tests a new stem cell treatment (ULSC) for people with FSHD, a type of muscular dystrophy. It aims to see if the treatment is safe and if it can help improve arm strength and daily movement.

Palo Alto, California
NCT07409142Recruiting
BetterLife FSHD health and research platform

This study creates a patient-driven health and research platform for people with FSHD. It aims to collect information to better understand the condition and improve future research and care.

Randolph, Massachusetts
NCT07038200Recruiting· Phase 3
Study of Del-brax (AOC 1020) for People with FSHD

This study tests an experimental medicine called Del-brax (AOC 1020) for people with facioscapulohumeral muscular dystrophy (FSHD). The goal is to see if it can help improve muscle strength and slow the disease. You may be able to join if you have a confirmed FSHD diagnosis and can walk at least 10 meters on your own.

Orange, California
NCT06917430Not yet recruiting
Muscle MRI with AI for neuromuscular diseases

This study uses artificial intelligence to analyze muscle MRI scans in people with genetically confirmed neuromuscular diseases. It aims to improve how these conditions are diagnosed and tracked.

NCT06847282Recruiting
Motor skills study for children with FSHD

This study looks at how children with FSHD move and function over time. It uses walking tests and optional MRI scans to understand muscle changes. Your child's participation could help researchers learn more about FSHD progression in kids.

Palo Alto, California

Hear when a new FSHD - Facioscapulohumeral Muscular Dystrophy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.